Modus Therapeutics Holding AB (publ) (STO:MODTX)

Market Cap	35.64M -24.6%
Revenue (ttm)	n/a
Net Income	-18.54M
EPS	-0.30
Shares Out	121.63M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,044
Average Volume	161,222
Open	0.3010
Previous Close	0.3020
Day's Range	0.2720 - 0.3010
52-Week Range	0.2080 - 5.0000
Beta	0.23
RSI	44.59
Earnings Date	Feb 25, 2026

About STO:MODTX

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MODTX